Guangdong Provincial Perople's Hospital
Guangdong Provincial Perople's Hospital
Guangzhou, Guangdong, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLC | ALK Positive Non-small Cell Lung Cancer | Recruiting | Phase 2 | 2023-10-23 | NCT06092086 |